Ieq Capital LLC Purchases Shares of 19,500 Chemed Corporation $CHE

Ieq Capital LLC purchased a new position in shares of Chemed Corporation (NYSE:CHEFree Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 19,500 shares of the company’s stock, valued at approximately $9,082,000. Ieq Capital LLC owned about 0.15% of Chemed at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Chemed by 2,444,879.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock valued at $2,374,667,000 after purchasing an additional 5,549,876 shares in the last quarter. BlackRock Inc. purchased a new stake in shares of Chemed during the 2nd quarter worth about $691,290,000. JPMorgan Chase & Co. increased its position in Chemed by 4.4% during the 4th quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock worth $223,301,000 after purchasing an additional 21,932 shares in the last quarter. AQR Capital Management LLC increased its position in Chemed by 89.2% during the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock worth $139,302,000 after purchasing an additional 153,469 shares in the last quarter. Finally, TD Asset Management Inc raised its holdings in Chemed by 7.5% in the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after buying an additional 22,715 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on CHE. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Oppenheimer increased their price target on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Royal Bank Of Canada raised their price objective on Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Finally, Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $530.75.

Check Out Our Latest Report on Chemed

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $539.51, for a total value of $1,079,020.00. Following the transaction, the chief executive officer owned 70,418 shares in the company, valued at $37,991,215.18. The trade was a 2.76% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Patrick P. Grace sold 190 shares of the company’s stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the transaction, the director directly owned 3,533 shares of the company’s stock, valued at approximately $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 3,537 shares of company stock valued at $1,782,654 in the last quarter. Company insiders own 3.33% of the company’s stock.

Chemed Stock Up 0.1%

NYSE CHE opened at $541.33 on Monday. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $557.00. The business has a 50 day moving average price of $499.24 and a two-hundred day moving average price of $446.50. The stock has a market cap of $7.08 billion, a PE ratio of 27.19, a P/E/G ratio of 2.05 and a beta of 0.51.

Chemed (NYSE:CHEGet Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. During the same quarter last year, the firm posted $4.27 earnings per share. The business’s quarterly revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, sell-side analysts predict that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be paid a dividend of $0.70 per share. This is a positive change from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 annualized dividend and a yield of 0.5%. Chemed’s payout ratio is presently 14.06%.

About Chemed

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Featured Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.